These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding. Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237 [TBL] [Abstract][Full Text] [Related]
8. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators. Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029 [TBL] [Abstract][Full Text] [Related]
9. Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia. Conde-Ceide S; Alcázar J; Alonso de Diego SA; López S; Martín-Martín ML; Martínez-Viturro CM; Pena MA; Tong HM; Lavreysen H; Mackie C; Bridges TM; Daniels JS; Niswender CM; Jones CK; Macdonald GJ; Steckler T; Conn PJ; Stauffer SR; Lindsley CW; Bartolomé-Nebreda JM Bioorg Med Chem Lett; 2016 Jan; 26(2):429-434. PubMed ID: 26684851 [TBL] [Abstract][Full Text] [Related]
10. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622 [TBL] [Abstract][Full Text] [Related]
12. Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition. Ellard JM; Madin A; Philps O; Hopkin M; Henderson S; Birch L; O'Connor D; Arai T; Takase K; Morgan L; Reynolds D; Talma S; Howley E; Powney B; Payne AH; Hall A; Gartlon JE; Dawson LA; Castro L; Atkinson PJ Bioorg Med Chem Lett; 2015 Dec; 25(24):5792-6. PubMed ID: 26531152 [TBL] [Abstract][Full Text] [Related]
13. Dihydrothiazolopyridone derivatives as a novel family of positive allosteric modulators of the metabotropic glutamate 5 (mGlu5) receptor. Bartolomé-Nebreda JM; Conde-Ceide S; Delgado F; Iturrino L; Pastor J; Pena MÁ; Trabanco AA; Tresadern G; Wassvik CM; Stauffer SR; Jadhav S; Gogi K; Vinson PN; Noetzel MJ; Days E; Weaver CD; Lindsley CW; Niswender CM; Jones CK; Conn PJ; Rombouts F; Lavreysen H; Macdonald GJ; Mackie C; Steckler T J Med Chem; 2013 Sep; 56(18):7243-59. PubMed ID: 23947773 [TBL] [Abstract][Full Text] [Related]
14. Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism. Bridges TM; Rook JM; Noetzel MJ; Morrison RD; Zhou Y; Gogliotti RD; Vinson PN; Xiang Z; Jones CK; Niswender CM; Lindsley CW; Stauffer SR; Conn PJ; Daniels JS Drug Metab Dispos; 2013 Sep; 41(9):1703-14. PubMed ID: 23821185 [TBL] [Abstract][Full Text] [Related]
15. Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold. Rodriguez AL; Zhou Y; Williams R; Weaver CD; Vinson PN; Dawson ES; Steckler T; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR Bioorg Med Chem Lett; 2012 Dec; 22(24):7388-92. PubMed ID: 23142615 [TBL] [Abstract][Full Text] [Related]
16. Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity. Rook JM; Noetzel MJ; Pouliot WA; Bridges TM; Vinson PN; Cho HP; Zhou Y; Gogliotti RD; Manka JT; Gregory KJ; Stauffer SR; Dudek FE; Xiang Z; Niswender CM; Daniels JS; Jones CK; Lindsley CW; Conn PJ Biol Psychiatry; 2013 Mar; 73(6):501-9. PubMed ID: 23140665 [TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators. Bennett KA; Christopher JA; Tehan BG Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871 [TBL] [Abstract][Full Text] [Related]
18. Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossover. Manka JT; Vinson PN; Gregory KJ; Zhou Y; Williams R; Gogi K; Days E; Jadhav S; Herman EJ; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Steckler T; Daniels JS; Weaver CD; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR Bioorg Med Chem Lett; 2012 Oct; 22(20):6481-5. PubMed ID: 22981332 [TBL] [Abstract][Full Text] [Related]
19. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology. Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015 [TBL] [Abstract][Full Text] [Related]
20. Discovery of 6,7-Dihydropyrazolo[1,5- Alonso de Diego SA; Linares ML; García Molina A; de Lucas AI; Del Cerro A; Alonso JM; Ver Donck L; Cid JM; Trabanco AA; Van Gool M J Med Chem; 2024 Sep; 67(17):15569-15585. PubMed ID: 39208150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]